A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients
Clinical trial NCT04004910 · UNKNOWN
Trial details
- NCT number
- NCT04004910
- Sponsor
- Immunicom Inc
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-31
- Primary completion
- 2022-12-31
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.